全髋关节置换术最小临床重要差异存在不一致:一项系统综述
该系统综述纳入30篇文献、242个最小临床重要差异(MCID)值,涉及45种患者报告结局测量工具(PROM)、1,000,874例患者。研究发现多数PROM的MCID值在不同计算方法间无显著差异,但部分常用PROM的锚定法MCID值大于分布法。作者推荐牛津髋关节评分(OHS)的MCID为9分,并推荐髋关节损伤与骨关节炎评分(HOOS)疼痛和的生活质量子量表的锚定法MCID分别为33分和25分。
要点
- OHS的锚定法中位MCID为9分(IQR 8-11),分布法中位值为6分(IQR 5-6)。
- HOOS疼痛子量表锚定法中位MCID为33分(IQR 28-35),分布法为10分(IQR 9-10)。
- 多数PROM(14个中的9个)的中位MCID值在不同计算方法间无显著差异(p>0.05)。
核心结论
- MCID在不同计算方法间差异不大,但部分常用PROM的锚定法值倾向于大于分布法值。
- 作者推荐OHS的MCID为9分,HOOS疼痛和的生活质量子量表的锚定法MCID分别为33分和25分。
- 作者鼓励使用WOMAC疼痛、功能和僵硬子量表的锚定法MCID值,分别为29、26和30分。
研究设计与样本
- 系统综述,检索EMBASE、MEDLINE和PubMed数据库自建库至2022年3月,纳入计算全髋关节置换术后PROM新MCID值的文章。
- 共纳入30篇文章,报告45种PROM的242个MCID值,总样本量1,000,874例患者,中位年龄64岁,中位BMI 28.7 kg/m²,女性占55%,中位随访12个月(范围0至77个月)。
- 使用改良的非随机研究方法学指数(MINORS)评估偏倚风险:比较性研究平均得分18/24分,非比较性研究平均得分10/16分,总体偏倚风险为中等。
主要发现
- 报告最多的MCID为OHS(12%,29/242)、HOOS疼痛子量表(8%,20/242)和HOOS生活质量子量表(8%,20/242),其次为EQ-VAS(7%,17/242)和EQ-5D(7%,16/242)。
- 30项研究中,30%(9/30)使用锚定法计算新MCID,40%(12/30)使用分布法,30%(9/30)同时使用两种方法。
- 锚定法中最常用的锚点为五点李克特量表评估疼痛缓解、满意度或生活质量(30%,8/27),其次为受试者工作特征曲线估计(22%,6/27);分布法中最常用方法为术前术后PROM评分差值标准差的一半(46%,12/26)。
- OHS的锚定法中位MCID为9(IQR 8-11),分布法中位值为6(IQR 5-6);HOOS疼痛子量表锚定法中位值为33(IQR 28-35),分布法为10(IQR 9-10);HOOS生活质量子量表锚定法中位值为25(IQR 14-27),分布法为13(IQR 10-14)。
- 多数PROM(14个中的9个)的中位MCID值在不同计算方法间无显著差异(p>0.05);OHS、HOOS JR以及HOOS功能、症状和日常生活活动子量表的MCID值因计算方法而异,锚定法值均大于相应的分布法值。
关键数值与推荐
- 作者推荐OHS的MCID为9分,与基于锚定法计算的多项高质量大样本研究报告的中位值一致。
- 作者推荐HOOS疼痛子量表的锚定法MCID为33分,HOOS生活质量子量表的锚定法MCID为25分。
- 作者鼓励使用WOMAC疼痛、功能和僵硬子量表的锚定法MCID值,分别为29、26和30分。
临床怎么用
- 作者推荐在全髋关节置换术临床研究中使用OHS的9分作为MCID。
- 作者推荐使用HOOS疼痛和的生活质量子量表的锚定法MCID值33分和25分。
- 作者鼓励使用WOMAC疼痛、功能和僵硬子量表的锚定法MCID值29、26和30分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The minimum clinically important difference (MCID) is intended to detect a change in a patient-reported outcome measure (PROM) large enough for a patient to appreciate. Their growing use in orthopaedic research stems from the necessity to identify a metric, other than the p value, to better assess the effect size of an outcome. Yet, given that MCIDs are population-specific and that there are multiple calculation methods, there is concern about inconsistencies. Given the increasing use of MCIDs in total hip arthroplasty (THA) research, a systematic review of calculated MCID values and their respective ranges, as well as an assessment of their applications, is important to guide and encourage their use as a critical measure of effect size in THA outcomes research. QUESTIONS/PURPOSES: We systematically reviewed MCID calculations and reporting in current THA research to answer the following: (1) What are the most-reported PROM MCIDs in THA, and what is their range of values? (2) What proportion of studies report anchor-based versus distribution-based MCID values? (3) What are the most common methods by which anchor-based MCID values are derived? (4) What are the most common derivation methods for distribution-based MCID values? (5) How do the reported medians and corresponding ranges compare between calculation methods for each PROM? METHODS: The EMBASE, MEDLINE, and PubMed databases were systematically reviewed from inception through March 2022 for THA studies reporting an MCID value for any PROMs. Two independent authors reviewed articles for inclusion. All articles calculating new PROM MCID scores after primary THA were included for data extraction and analysis. MCID values for each PROM, MCID calculation method, number of patients, and study demographics were extracted from each article. In total, 30 articles were included. There were 45 unique PROMs for which 242 MCIDs were reported. These studies had a total of 1,000,874 patients with a median age of 64 years and median BMI of 28.7 kg/m 2 . Women made up 55% of patients in the total study population, and the median follow-up period was 12 months (range 0 to 77 months). The overall risk of bias was assessed as moderate using the modified Methodological Index for Nonrandomized Studies criteria for comparative studies (the mean score for comparative papers in this review was 18 of 24, with higher scores representing better study quality) and noncomparative studies (for these, the mean score was 10 of a possible 16 points, with higher scores representing higher study quality). Calculated values were classified as anchor-based, distribution-based, or not reported. MCID values for each PROM, MCID calculation method, number of patients, and study demographics were extracted from each study. Anchor-based and distribution-based MCIDs were compared for each unique PROM using a Wilcoxon rank sum test, given the non-normal distribution of values. RESULTS: The Oxford Hip Score (OHS) and the Hip Injury and Osteoarthritis Score (HOOS) Pain and Quality of Life subscore MCIDs were the most frequently reported, comprising 12% (29 of 242), 8% (20 of 242), and 8% (20 of 242), respectively. The EuroQol VAS (EQ-VAS) was the next-most frequently reported (7% [17 of 242]) followed by the EuroQol 5D (EQ-5D) (7% [16 of 242]). The median anchor-based value for the OHS was 9 (IQR 8 to 11), while the median distribution-based value was 6 (IQR 5 to 6). The median anchor-based MCID values for HOOS Pain and Quality of Life were 33 (IQR 28 to 35) and 25 (14 to 27), respectively; the median distribution-based values were 10 (IQR 9 to 10) and 13 (IQR 10 to 14), respectively. Thirty percent (nine of 30) of studies used an anchor-based method to calculate a new MCID, while 40% (12 of 30) used a distribution-based technique. Thirty percent of studies (nine of 30) calculated MCID values using both methods. For studies reporting an anchor-based calculation method, a question assessing pain relief, satisfaction, or quality of life on a five-point Likert scale was the most commonly used anchor (30% [eight of 27]), followed by a receiver operating characteristic curve estimation (22% [six of 27]). For studies using distribution-based calculations, the most common method was one-half the standard deviation of the difference between preoperative and postoperative PROM scores (46% [12 of 26]). Most reported median MCID values (nine of 14) did not differ by calculation method for each unique PROM (p > 0.05). The OHS, HOOS JR, and HOOS Function, Symptoms, and Activities of Daily Living subscores all varied by calculation method, because each anchor-based value was larger than its respective distribution-based value. CONCLUSION: We found that MCIDs do not vary very much by calculation method across most outcome measurement tools. Additionally, there are consistencies in MCID calculation methods, because most authors used an anchor question with a Likert scale for the anchor-based approach or used one-half the standard deviation of preoperative and postoperative PROM score differences for the distribution-based approach. For some of the most frequently reported MCIDs, however, anchor-based values tend to be larger than distribution-based values for their respective PROMs. CLINICAL RELEVANCE: We recommend using a 9-point increase as the MCID for the OHS, consistent with the median reported anchor-based value derived from several high-quality studies with large patient groups that used anchor-based approaches for MCID calculations, which we believe are most appropriate for most applications in clinical research. Likewise, we recommend using the anchor-based 33-point and 25-point MCIDs for the HOOS Pain and Quality of Life subscores, respectively. We encourage using anchor-based MCID values of WOMAC Pain, Function, and Stiffness subscores, which were 29, 26, and 30, respectively.
引用
- Deckey DG, Verhey JT, Christopher ZK, et al. Discordance Abounds in Minimum Clinically Important Differences in THA: A Systematic Review. Clin Orthop Relat Res. 2022. PMID: 36398323. doi:10.1097/CORR.0000000000002434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。